CERT – certara, inc. (US:NASDAQ)
Stock Stats
News
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions [Yahoo! Finance]
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
Certara, Inc. (NASDAQ: CERT) had its price target raised by analysts at Barclays PLC from $12.00 to $13.00. They now have an "equal weight" rating on the stock.
Certara, Inc. (NASDAQ: CERT) had its "market perform" rating re-affirmed by analysts at William Blair.
Certara, Inc. (NASDAQ: CERT) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $17.00 price target on the stock.
Form 3 Certara, Inc. For: Mar 03 Filed by: McKemey Adrian
Form 8-K Certara, Inc. For: Mar 03
Form 10-K Certara, Inc. For: Dec 31
Form 8-K Certara, Inc. For: Feb 26
Form SCHEDULE 13G/A Certara, Inc. Filed by: Mubadala Investment Co PJSC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.